These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1384920)

  • 21. Which patients with prostatic carcinoma require a staging bone scan?
    Kemp PM; Maguire GA; Bird NJ
    Br J Urol; 1997 Apr; 79(4):611-4. PubMed ID: 9126094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?
    Wolff JM; Zimny M; Borchers H; Wildberger J; Buell U; Jakse G
    Eur Urol; 1998; 33(4):376-81. PubMed ID: 9612680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?
    Bantis A; Grammaticos P
    Hell J Nucl Med; 2012; 15(3):241-6. PubMed ID: 23227460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
    Morote J; Lorente JA; Encabo G
    Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of bone scintigraphy, prostatic acid phosphatase and prostate-specific antigen to the monitoring of prostatic cancer.
    Hetherington JW; Siddall JK; Cooper EH
    Eur Urol; 1988; 14(1):1-5. PubMed ID: 2449352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications.
    Oesterling JE
    Urol Clin North Am; 1993 Nov; 20(4):705-11. PubMed ID: 7505979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population.
    Lai MH; Luk WH; Chan JC
    Urol Oncol; 2011; 29(3):275-9. PubMed ID: 19734069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
    Wang ZL; Wang XF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone scan in initial staging of prostate cancer.
    Boughattas S; Letaief B; Hassine H; Chatti K; Essabah H
    Tunis Med; 2003 Jun; 81(6):400-6. PubMed ID: 14534946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.
    Wolff JM; Bares R; Jung PK; Buell U; Jakse G
    Urol Int; 1996; 56(3):169-73. PubMed ID: 8860738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is it suitable to eliminate bone scan for prostate cancer patients with PSA ≤ 20 ng/mL?
    Lee SH; Chung MS; Park KK; Yom CD; Lee DH; Chung BH
    World J Urol; 2012 Apr; 30(2):265-9. PubMed ID: 21779835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer.
    Murphy GP; Troychak MJ; Cobb OE; Bowes VA; Kenny RJ; Barren RJ; Kenny GM; Ragde H; Holmes EH; Wolfert RL
    Prostate; 1997 Oct; 33(2):141-6. PubMed ID: 9316655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between low Gleason score and prostate specific antigen levels with incidence of bone metastases in prostate cancer patients: when to omit bone scans?
    Sanjaya IP; Mochtar CA; Umbas R
    Asian Pac J Cancer Prev; 2013; 14(9):4973-6. PubMed ID: 24175761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reappraisal of serial isotope bone scans in prostate cancer.
    O'Donoghue JM; Rogers E; Grimes H; McCarthy P; Corcoran M; Bredin H; Given HF
    Br J Radiol; 1993 Aug; 66(788):672-6. PubMed ID: 7536607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of a baseline bone scan in patients with newly diagnosed prostate cancer.
    Lin K; Szabo Z; Chin BB; Civelek AC
    Clin Nucl Med; 1999 Aug; 24(8):579-82. PubMed ID: 10439178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate-specific antigen as a unique routine test in monitoring therapy for inoperable prostate cancer: comparison with radionuclide bone scan and prostatic acid phosphatase.
    Barichello M; Gion M; Bonazza A; Delli Ponti US; Bolgan A; Contemori GP; Barioli P; Capitanio G; Pecori B; Omacini S
    Eur Urol; 1995; 27(4):295-300. PubMed ID: 7544735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
    Kageyama Y; Kihara K; Kamata S; Nagahama K; Yonese J; Fukuda H; Tosaka A; Nagamatsu H; Ishizaka K; Tsujii T; Kitahara S; Morita T; Oshima H
    Hinyokika Kiyo; 1996 Mar; 42(3):197-9. PubMed ID: 8619388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of prostate specific antigen (PSA), C-terminal propeptide of blood type I procollagen (PICP) and urine type I collagen-crosslinked N telopeptide (NTx) levels using bone scintigraphy in prostate cancer patients.
    Fukumitsu N; Uchiyama M; Mori Y; Kishimoto K; Nakada J
    Ann Nucl Med; 2003 Jun; 17(4):297-303. PubMed ID: 12932112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients.
    Lee N; Fawaaz R; Olsson CA; Benson MC; Petrylak DP; Schiff PB; Bagiella E; Singh A; Ennis RD
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1443-6. PubMed ID: 11121646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of PSA, ALP, ICTP, and BSP in prostate cancer patients and the significance of ROC curve in the diagnosis of prostate cancer bone metastases.
    Wei RJ; Li TY; Yang XC; Jia N; Yang XL; Song HB
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.